Shield Therapeutics PLC (1JS.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
As of 09:26AM CEST. Market open.
| Previous Close | 0.0120 |
| Open | 0.0120 |
| Bid | 0.0120 x 500000 |
| Ask | 0.0190 x 500000 |
| Day's Range | 0.0120 - 0.0120 |
| 52 Week Range | 0.0120 - 0.1400 |
| Volume | |
| Avg. Volume | 4,479 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Simply Wall St.Shield Therapeutics (LON:STX) shareholders have endured a 89% loss from investing in the stock three years ago
Every investor on earth makes bad calls sometimes. But you want to avoid the really big losses like the plague. So...
- Simply Wall St.
Shield Therapeutics plc (LON:STX) Is Expected To Breakeven In The Near Future
With the business potentially at an important milestone, we thought we'd take a closer look at Shield Therapeutics...
News DirectShield Therapeutics' pricing will be "key metric" - Proactive Research Analyst
Proactive Research Analyst Robin Davison speaks to Thomas Warner after publishing a new research note on iron defiency-focused commercial-stage specialty pharmaceutical company Shield Therapeutics.
© 2024 Yahoo. All rights reserved.